As the world leader in Vitamin K2 Research and Development, NattoPharma has invested heavily in in-vitro, in-vivo, and clinical studies to substantiate and document the efficacy of MenaQ7® Vitamin K2 as MK-7 for bone and cardiovascular health. This commitment has created the only clinically validated and patented Vitamin K2 on the market.
NattoPharma is fully committed to educating consumers and practitioners about the nutritional benefits of Vitamin K2, and to providing the highest quality raw material to the marketplace so manufacturers can create products that deliver on the promise of improving health. Our team is eager to answer your questions.
To learn more about the NattoPharma team and/or to subscribe to the company newsletter, visit www.nattopharma.com.
0283 Oslo, Norway
NattoPharma USA, Inc.
(North American Subsidiary)
95 Newfield Ave., Suite C
Edison, NJ 08837